Peritoneal Dialysis
Peritoneal dialysis (PD) is a treatment that uses the lining of your abdomen (belly area), called your peritoneum, and a cleaning solution called dialysate to clean your blood. Dialysate absorbs waste and fluid from your blood, using your peritoneum as a filter. One benefit of PD is that it is not done in a dialysis center. You can do your PD treatment any place that is clean and dry. This can allow you more freedom to work, travel or do other activities you enjoy without worrying about scheduling dialysis appointments. The two most common types of PD are continuous ambulatory PD (CAPD) and continuous cycler-assisted PD (CCPD). Your doctor can help you decide which is right for you.
The benefits of peritoneal dialysis compared with hemodialysis can include:
- Greater lifestyle flexibility and independence. These can be especially important if you work, travel or live far from a hemodialysis center.
- More flexible dietary guidelines. Peritoneal dialysis is done more continuously than hemodialysis, resulting in less accumulation of potassium, sodium and fluid.
- More stable blood chemistry and body hydration. Peritoneal dialysis doesn't require intravenous (IV) access, which can disrupt your circulation and fluid levels.
- Longer lasting residual kidney function. People who use peritoneal dialysis might retain kidney function slightly longer than people who use hemodialysis.
Risks
Complications of peritoneal dialysis can include:
- Infections. An infection of the abdominal lining (peritonitis) is a common complication of peritoneal dialysis. An infection can also develop at the site where the catheter is inserted to carry the cleansing fluid (dialysate) into and out of your abdomen. The risk of infection is greater if the person doing the dialysis isn't adequately trained.
- Weight gain. The dialysate contains sugar (dextrose). Absorbing some of the dialysate might cause you to take in several hundred extra calories a day, leading to weight gain. The extra calories can also cause high blood sugar, especially if you have diabetes.
- Hernia. Holding fluid in your abdomen for long periods may strain your muscles.
- Inadequate dialysis. Peritoneal dialysis can become ineffective after several years. You might need to switch to hemodialysis.
If you have peritoneal dialysis, you'll need to avoid:
- Certain prescription and over-the-counter medications that can damage your kidneys, including nonsteroidal anti-inflammatory drugs.
- Soaking in a bath or hot tub, or swimming in a lake, pond, river or nonchlorinated pool — which increases the risk of infection. Showers and swimming in a chlorinated pool are generally acceptable.
How you prepare
You'll receive training on what peritoneal dialysis involves and how to use the equipment.
You'll also need an operation to insert the catheter that carries the dialysate in and out of your abdomen. The insertion might be done under local or general anesthesia. The tube is usually inserted near your bellybutton.
After the tube is inserted, your doctor will probably recommend waiting at least two weeks before starting peritoneal dialysis treatments to give the catheter site time to heal. Complete healing of the catheter site can take up to two months.
What you can expect
During peritoneal dialysis:
- The dialysate flows into your abdomen and stays there for a prescribed period of time (dwell time) — usually four to six hours
- Dextrose in the dialysate helps filter waste, chemicals and extra fluid in your blood from tiny blood vessels (capillaries) in the lining of your abdominal cavity (peritoneum)
- When the dwell time is over, the solution — along with waste products drawn from your blood — drains into a sterile collection bag
The process of filling and then draining your abdomen is called an exchange. Different methods of peritoneal dialysis have different schedules of exchange. The two main schedules are:
- Continuous ambulatory peritoneal dialysis (CAPD)
- Continuous cycling peritoneal dialysis (CCPD)
Continuous ambulatory peritoneal dialysis (CAPD)
You fill your abdomen with dialysate, let it remain there for a prescribed dwell time, then drain the fluid. Gravity moves the fluid through the catheter and into and out of your abdomen.
With CAPD:
- You may need three to five exchanges during the day and one with a longer dwell time while you sleep
- You can do the exchanges at home, work or any clean place
- You're free to go about your normal activities while the dialysate dwells in your abdomen
Continuous cycling peritoneal dialysis (CCPD)
Also known as automated peritoneal dialysis (APD), this method uses a machine (automated cycler) that performs multiple exchanges at night while you sleep. The cycler automatically fills your abdomen with dialysate, allows it to dwell there and then drains it to a sterile bag that you empty in the morning.
With CCPD:
- You must remain attached to the machine for 10 to 12 hours at night.
- You aren't connected to the machine during the day. But in the morning you begin one exchange with a dwell time that lasts the entire day.
- You might have a lower risk of peritonitis because you connect and disconnect to the dialysis equipment less frequently than you do with CAPD.
To determine the method of exchange that's best for you, your doctor will consider your medical condition, lifestyle and personal preferences. Your doctor might suggest certain modifications to individualize your program.
Results
Many factors affect how well peritoneal dialysis works in removing wastes and extra fluid from your blood. These factors include:
- Your size
- How quickly your peritoneum filters waste
- How much dialysis solution you use
- The number of daily exchanges
- Length of dwell times
- The concentration of sugar in the dialysis solution
To check if your dialysis is removing enough waste products, your doctor is likely to recommend:
- Peritoneal equilibration test (PET). This test compares samples of your blood and your dialysis solution during an exchange. The results indicate whether waste toxins pass quickly or slowly from your blood into the dialysate. That information helps determine whether your dialysis would be improved if the solution stayed in your abdomen for a shorter or longer time.
- Clearance test. A blood sample and a sample of used dialysis solution are analyzed to determine how much of a certain waste product (urea) is being removed from your blood during dialysis. If you still produce urine, your doctor may also take a urine sample to measure its urea concentration.
If the test results show that your dialysis schedule is not removing enough wastes, your doctor might change your dialysis routine to:
- Increase the number of exchanges
- Increase the amount of dialysate you use for each exchange
- Use a dialysate with a higher concentration of dextrose
You can improve your dialysis results and your overall health by eating the right foods, including foods low in sodium and phosphorus. A dietitian can help you develop an individualized meal plan based on your weight; your personal preferences; and your remaining kidney function and other medical conditions, such as diabetes or high blood pressure.
Taking your medications as prescribed also is important for getting the best possible results. While you're receiving peritoneal dialysis, you'll likely need various medications to control your blood pressure, stimulate production of red blood cells, control the levels of certain nutrients in your blood and prevent the buildup of phosphorus in your blood.
- Abdominal hernias in continuous peritoneal dialysis
- Bloody peritoneal dialysate (hemoperitoneum)
- Evaluation of hypervolemia in peritoneal dialysis patients
- Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis
- Microbiology and therapy of peritonitis in continuous peritoneal dialysis
- Modalities for the diagnosis of abdominal and thoracic cavity defects in peritoneal dialysis patients
- Noninfectious complications of continuous peritoneal dialysis
- Noninfectious complications of peritoneal dialysis catheters
- Pathophysiology and prevention of peritonitis in peritoneal dialysis
- Peritoneal dialysis solutions
- Peritoneal equilibration test
- Placement and maintenance of the peritoneal dialysis catheter
- Prescribing and assessing adequate peritoneal dialysis
- Problems with solute clearance and ultrafiltration in continuous peritoneal dialysis
- Rapid transporters on maintenance peritoneal dialysis
- Tunnel and peritoneal catheter exit site infections in continuous peritoneal dialysis
- Urgent-start peritoneal dialysis
- Use of peritoneal dialysis for the treatment of acute kidney injury in adults
Related Conference of Peritoneal Dialysis
7th International Conference on Clinical Immunology, Neuropharmacology and Drug Development
Peritoneal Dialysis Conference Speakers
Recommended Sessions
- Acute Renal Failure and Dialysis
- Anemia and Chronic Renal Failure
- Cardiac Disease and Hypertension
- Complications during Dialysis
- Dialysis Adequacy
- Dialysis Modalities
- Endocrine Dysfunction
- Hemodialysis
- Infection and Dialysis
- Intoxications
- Nutrition
- Other
- Peritoneal Dialysis
- Slow Continuous Therapies
- Vascular access
Related Journals
Are you interested in
- Acute Kidney Injury - Kidney Care 2026 (UK)
- Acute Kidney Injury (AKI) - Nephrology 2025 (France)
- Advanced Imaging Techniques in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Advances in Immuno-Oncology for CNS Tumors - Neuropharmacology 2025 (Italy)
- Advances in Kidney Transplantation - Nephrologists 2025 (France)
- AI-Driven Drug Discovery in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Artificial Intelligence (AI) and Digital Health in Nephrology - Nephrology 2025 (France)
- Artificial Intelligence and Machine Learning in Renal Diagnostics - EURO NEPHROLOGY 2025 (Italy)
- Artificial Intelligence in Nephrology - World Nephrology 2026 (Netherlands)
- Autoimmune Kidney Diseases - Nephrology 2025 (France)
- Autoimmunity and Neuropharmacology: New Insights - Neuropharmacology 2025 (Italy)
- Biomarkers and Molecular Mechanisms in Renal Diseases - Nephrology 2025 (France)
- Biomarkers in Kidney Disease - KIDNEY MEET 2025 (UK)
- Biomarkers in Neuroimmune and Neuroinfectious Diseases - Neuropharmacology 2025 (Italy)
- Blood-Brain Barrier: Challenges and Solutions - Neuropharmacology 2025 (Italy)
- Cardio-Renal Syndrome - World Nephrology 2026 (Netherlands)
- Cardiovascular Impact of Kidney Disease - KIDNEY MEET 2025 (UK)
- Cell-Based Therapies in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Challenges in Paediatric Nephrology - Nephrologists 2025 (France)
- Chronic Kidney Disease - KIDNEY MEET 2025 (UK)
- Chronic Kidney Disease (CKD) - Nephrology 2025 (France)
- Chronic Kidney Disease (CKD): Global Epidemiology & Prevention - World Nephrology 2026 (Netherlands)
- Chronic Kidney Disease and Diabetes - Nephrologists 2025 (France)
- Clinical Nephrology - Kidney Care 2026 (UK)
- Clinical Trails in Kidney Therapy - Nephrologists 2025 (France)
- Clinical Trials and Research in Nephrology - Nephrology 2025 (France)
- Clinical Trials in Neuroimmunology - Neuropharmacology 2025 (Italy)
- CRISPR Innovations for Kidney Disorders - EURO NEPHROLOGY 2025 (Italy)
- Critical Care Nephrology - KIDNEY MEET 2025 (UK)
- Diabetic Nephropathy - KIDNEY MEET 2025 (UK)
- Diabetic Nephropathy - Kidney Care 2026 (UK)
- Diabetic Nephropathy and Metabolic Syndrome - Nephrology 2025 (France)
- Dialysis - KIDNEY MEET 2025 (UK)
- Dialysis – Hemodialysis and Peritoneal Dialysis - Nephrology 2025 (France)
- Digital Health Innovations and Biomarker Development - EURO NEPHROLOGY 2025 (Italy)
- Drugs for Kidney Disease - KIDNEY MEET 2025 (UK)
- Drugs for Kidney Diseases - Kidney Care 2026 (UK)
- Emerging Biomarkers in Nephrology - Nephrologists 2025 (France)
- Emerging Neuroprotective Agents - Neuropharmacology 2025 (Italy)
- Emerging Therapies for Polycystic Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Environmental and Occupational Nephrology - World Nephrology 2026 (Netherlands)
- Environmental Risk Factors and Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Epidemiology and the Global Burden of Kidney Diseases - Nephrology 2025 (France)
- Epigenetic Modulation in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Ethical and Regulatory Considerations in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Ethical, Legal, and Policy Issues - Nephrology 2025 (France)
- Ethics and Policy in Renal Medicine - EURO NEPHROLOGY 2025 (Italy)
- Ethics in Kidney Donation and Transplantation - Nephrologists 2025 (France)
- Ethics in Kidney Transplantation - EURO NEPHROLOGY 2025 (Italy)
- Fluid and Electrolyte Disorders in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Gene Therapy and CRISPR in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Genetic and Rare Kidney Disorders - World Nephrology 2026 (Netherlands)
- Genetics and Hereditary Renal Disorders - Nephrology 2025 (France)
- Genetics of Kidney Disease - Nephrologists 2025 (France)
- Geriatric Nephrology - Kidney Care 2026 (UK)
- Geriatric Nephrology and Aging Populations - EURO NEPHROLOGY 2025 (Italy)
- Geriatric Nephrology: Managing the Aging Kidney - World Nephrology 2026 (Netherlands)
- Global Perspectives on kidney Health - Nephrologists 2025 (France)
- Glomerular and Tubulointerstitial Diseases - Nephrology 2025 (France)
- Glomerular Diseases and Management - World Nephrology 2026 (Netherlands)
- Hypertension & Kidney Health - World Nephrology 2026 (Netherlands)
- Hypertension and Renal Vascular Disorders - Nephrology 2025 (France)
- Hypertension effect on kidney - KIDNEY MEET 2025 (UK)
- Immunology and Inflammatory Kidney Diseases - Nephrology 2025 (France)
- Immunomodulation and Targeted Therapies for Glomerular Diseases - EURO NEPHROLOGY 2025 (Italy)
- Immunomodulation in Stroke and Traumatic Brain Injury - Neuropharmacology 2025 (Italy)
- Infection and Immunity in Renal Diseases - World Nephrology 2026 (Netherlands)
- Infections and Renal Complications - Nephrology 2025 (France)
- Innovations in Dialysis Techniques - Nephrologists 2025 (France)
- Innovations in Home-Based Renal Therapy: Smart Dialysis Devices - EURO NEPHROLOGY 2025 (Italy)
- Innovations in Nephrology Devices and Technology - Nephrology 2025 (France)
- Innovative Approaches to Stone Disease - Nephrologists 2025 (France)
- Innovative Dialysis Modalities - World Nephrology 2026 (Netherlands)
- Integrating care for Kidney Failure - Nephrologists 2025 (France)
- Kidney and Bladder Cancer - Kidney Care 2026 (UK)
- Kidney Disease in Aging Population - Nephrologists 2025 (France)
- Kidney Diseases & Diagnosis of Kidney Diseases - Kidney Care 2026 (UK)
- Kidney Failure - KIDNEY MEET 2025 (UK)
- Kidney Health and Nutrition - Nephrologists 2025 (France)
- Kidney Stones - KIDNEY MEET 2025 (UK)
- Kidney Transplantation - KIDNEY MEET 2025 (UK)
- Kidney Transplantation - Kidney Care 2026 (UK)
- Kidney Transplantation and Organ Preservation - Nephrology 2025 (France)
- Kidney Transplantation: Advances & Ethical Considerations - World Nephrology 2026 (Netherlands)
- Kidney-on-a-Chip Technology - EURO NEPHROLOGY 2025 (Italy)
- Managing Chronic Kidney Disease - Nephrologists 2025 (France)
- Mental Health in Nephrology Patients - World Nephrology 2026 (Netherlands)
- Microbiome-Targeted Therapies in Neurology - Neuropharmacology 2025 (Italy)
- Mineral and Bone Disorder in CKD - KIDNEY MEET 2025 (UK)
- Minimally Invasive Urological surgery - Nephrologists 2025 (France)
- Molecular Mechanisms of Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Nanomedicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Nanotechnology in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Nephrology - Kidney Care 2026 (UK)
- Nephrology and Cardiovascular Comorbidities - Nephrology 2025 (France)
- Nephrology Nursing - KIDNEY MEET 2025 (UK)
- Nephrology Nursing - Kidney Care 2026 (UK)
- Nephrology Nursing and Allied Health Roles - World Nephrology 2026 (Netherlands)
- Nephrology Nursing and Patient Care - Nephrology 2025 (France)
- Nephrotoxicity and Drug-induced Kidney Injury - Nephrology 2025 (France)
- Neuroimmune Crosstalk in Metabolic Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Interactions in Psychiatric Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Pathways in Pain Management - Neuropharmacology 2025 (Italy)
- Neuroinflammation: Mechanisms and Therapeutic Strategies - Neuropharmacology 2025 (Italy)
- Neuropharmacological Interventions in Neurodegenerative Disorders - Neuropharmacology 2025 (Italy)
- Neurotoxicology and Immunotoxicology - Neuropharmacology 2025 (Italy)
- Next-Generation Immunotherapies in Neurological Disorders - Neuropharmacology 2025 (Italy)
- Novel Drug Delivery Systems for Neuroimmune Agents - Neuropharmacology 2025 (Italy)
- Nutrition and Lifestyle in Kidney Health - Nephrology 2025 (France)
- Nutrition and Lifestyle in Kidney Health - World Nephrology 2026 (Netherlands)
- Nutritional Genomics and Personalized Renal Dietetics - EURO NEPHROLOGY 2025 (Italy)
- Patient-Centered Care and Advocacy - World Nephrology 2026 (Netherlands)
- Patient-Centric Kidney Care - Nephrologists 2025 (France)
- Pediatric Nephrology - Kidney Care 2026 (UK)
- Pediatric Nephrology and Developmental Disorders - EURO NEPHROLOGY 2025 (Italy)
- Pediatric Nephrology and Developmental Nephrology - Nephrology 2025 (France)
- Pediatric Nephrology: Growing Concerns in Children - World Nephrology 2026 (Netherlands)
- Pediatric Neuroimmunology: Challenges and Innovations - Neuropharmacology 2025 (Italy)
- Pediatrics and Geriatric Nephrology - KIDNEY MEET 2025 (UK)
- Personalized Medicine in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Pharmacogenomics and Personalized Medicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Pharmacogenomics in Renal Drug Response - EURO NEPHROLOGY 2025 (Italy)
- Pharmacology and Nephrotherapeutics - Nephrology 2025 (France)
- Precision Medicine in Kidney Care - World Nephrology 2026 (Netherlands)
- Precision Neuropharmacology: From Bench to Bedside - Neuropharmacology 2025 (Italy)
- Preventing Acute Kidney Injury - Nephrologists 2025 (France)
- Psychosocial aspects of Kidney Disease - Nephrologists 2025 (France)
- Public Health and Kidney Disease Prevention - Nephrology 2025 (France)
- Regenerative Medicine and Stem Cell Therapies - World Nephrology 2026 (Netherlands)
- Regenerative Medicine and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Regenerative Medicine in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Renal Nutrition - KIDNEY MEET 2025 (UK)
- Renal Nutrition and Metabolism - Kidney Care 2026 (UK)
- Renal Oncology – Kidney Cancers and Tumors - Nephrology 2025 (France)
- Renal Pathology & Immunology - Kidney Care 2026 (UK)
- Renal Pathology and Diagnostic Imaging - Nephrology 2025 (France)
- Renal Pathology and Immunology - KIDNEY MEET 2025 (UK)
- Renal Replacement Therapy & Future Trends - Nephrology 2025 (France)
- Robotic kidney Transplantation - KIDNEY MEET 2025 (UK)
- Robotic Surgery - Kidney Care 2026 (UK)
- Role of Pharmacotherapy in Nephrology - Nephrologists 2025 (France)
- Sophisticated Imaging: 3D Mapping and Evaluation - EURO NEPHROLOGY 2025 (Italy)
- Stem Cell and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Stem Cells in Renal Disorders - KIDNEY MEET 2025 (UK)
- Telehealth in Urology - Nephrologists 2025 (France)
- Telemedicine and Home Dialysis Advancements - Nephrology 2025 (France)
- The End Stage Renal Diseases & Chronic Kidney Diseases - Kidney Care 2026 (UK)
- The Neuroimmune Interface in Autoimmune Diseases - Neuropharmacology 2025 (Italy)
- The Role of AI in Nephrology - Nephrologists 2025 (France)
- Understanding Glomerular Diseases - Nephrologists 2025 (France)
- Urological Emergencies: Quick Response - Nephrologists 2025 (France)
- Urological Oncology: Current Trends - Nephrologists 2025 (France)
- Urology - KIDNEY MEET 2025 (UK)
- Urology / Urinary Tract Infections - Kidney Care 2026 (UK)
- Urology and Kidney Stone Management - Nephrology 2025 (France)
- Urology and Sexual Health - Nephrologists 2025 (France)
- Viral Infections and Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Women Health and Pregnancy - KIDNEY MEET 2025 (UK)
- Women’s Health and Kidney Disorders - Nephrology 2025 (France)